Usana Health Sciences (USNA) Gross Profit (2010 - 2026)

Usana Health Sciences (USNA) has 17 years of Gross Profit data on file, last reported at $190.8 million in Q2 2026.

• Gross Profit for Q2 2026 came in at $190.8 million, down 3.2% year-over-year; the trailing twelve-month figure through Apr 2026 was $718.1 million (up 1.76% YoY), and the FY2026 annual result was $724.4 million, up 4.49% from the prior year.
• Gross Profit climbed to $190.8 million in Q2 2026 per USNA's latest filing, from $176.8 million in the prior quarter.
• Over five years, Gross Profit peaked at $294.5 million in Q1 2022 and troughed at $161.0 million in Q3 2024.
• A 5-year average of $191.8 million and a median of $185.2 million in 2024 frame the typical range for Gross Profit.
• The sharpest annual moves came in 2022 and 2025: Gross Profit slumped 38.37% in 2022, then increased 7.61% in 2025.
• A 5-year view of Gross Profit shows it stood at $181.5 million in 2022, then dropped by 1.52% to $178.8 million in 2023, then slipped by 2.07% to $175.1 million in 2024, then decreased by 5.83% to $164.9 million in 2025, then advanced by 15.73% to $190.8 million in 2026.
• Business Quant data shows USNA's Gross Profit at $190.8 million in Q2 2026, $176.8 million in Q1 2026, and $164.9 million in Q3 2025.